BioGenerator
VC Fund
St Louis, United States
BioGenerator is a VC fund in St Louis focused on Biotechnology and Health Care. The BioGenerator, the non-profit venture development organization of BioSTL, facilitates the formation of successful, sustainable bioscience companies in the St. Louis region. It provides start-up bioscience companies with pre-seed and seed investment funds, shared lab space with specialized equipment, and in-depth management support.
- Total investments:
- 79
- Last investment:
- Lead investor:
- 32%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries BioGenerator invests in
Stages BioGenerator invests in
Countries BioGenerator invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Charlie Bolten
|
|||
David Christenson
|
|||
Dennis Schafer
|
|||
Nandini Kishore
|
|||
| See all 11 contacts → | |||
Investment Focus
Industry
- Biotechnology 38 (48%)
- Health Care 30 (38%)
- Agriculture 10 (13%)
- Life Science 9 (11%)
- Medical Device 8 (10%)
Stage
- Seed 32 (41%)
- Series A 12 (15%)
- Funding Round 12 (15%)
- Grant 5 (6%)
- Series B 4 (5%)
Country
- United States 56 (71%)
- Argentina 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Charlie Bolten
Vice President
|
Vice President | Total investments: 7 | Find email | |
Dan Broderick
Vice President
|
Vice President | Total investments: 2 | Find email | |
|
David Christenson
Entrepreneur In Residence
|
Entrepreneur In Residence | Total investments: 0 | Find email | |
|
Dennis Schafer
Senior Entrepreneur in Residence
|
Senior Entrepreneur in Residence | Total investments: 0 | Find email | |
|
Nandini Kishore
Entrepreneur in Residence
|
Entrepreneur in Residence | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
IN10T
|
IN10T is a digital agriculture company, focused on solving farmer adoption challenges in agriculture. We create custom digital and data science solutions for our customers both in agriculture and those investing in agriculture. | Aug 02, 2023 | |
|
IN10T
|
IN10T is a digital agriculture company, focused on solving farmer adoption challenges in agriculture. We create custom digital and data science solutions for our customers both in agriculture and those investing in agriculture. | Series A / Aug 02, 2023 | |
Solis Agrosciences
|
Solis Agrosciences provides R&D crop development services to Agtech companies. Founded in 2021, Solis Agrosciences is a plant science services company on a mission to accelerate the pace of scientific discovery and commercialization. | $3.1M / Seed / Dec 07, 2022 | |
Peptyde Bio
|
Peptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs. | $1.2M / Pre-Seed / Nov 15, 2022 | |
Plastomics
|
Plastomics is a biotechnology startup that focuses in developing the next generation of crops by using chloroplast genetic engineering. Its technology platform is applicable to different crops and traits. Plastomics provides solutions for the many current industry challenges.The company was founded in 2016 and headquartered in St. Louis,Missouri. | $7.1M / Series A / Nov 16, 2021 | |
Geneoscopy
|
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasivecolonoscopy. Geneoscopy is changing that.It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications. | $105M / Series B / Nov 16, 2021 | |
Buck Surgical
|
A medical device company committed to revolutionizing surgical care and expanding patient access to life and limb-preserving treatments. | $16.5K / Grant / Sep 03, 2021 | |
Impetus Agriculture
|
Impetus Agriculture focuses on developing multiple topical or transgenic insect control products. Products that are safe, effective, and sustainable. Products that are not subject to the same insect resistance that has developed in current commercial products. | $1M / Seed / Jun 04, 2021 | |
SentiAR
|
SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission. | $5.1M / Series A / Apr 13, 2021 | |
CuriMeta
|
CuriMeta is a real-world health data firm with a focus on life sciences. | Pre-Seed / Dec 01, 2020 | |
| See all 79 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BioGenerator invest in?
BioGenerator invests primarily in Biotechnology, Health Care and Agriculture startups, most often at Seed and Series A stage. Most of the 79 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BioGenerator?
Public channels for BioGenerator include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BioGenerator?
The team at BioGenerator includes Charlie Bolten (Vice President), Dan Broderick (Vice President) and David Christenson (Entrepreneur In Residence), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
